Related content

PK-PD modeling of combination efficacy effect from administration of the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 in A2058 xenografts

By Choo Edna   Ng Chee   Berry Leanne   Belvin Marcia   Lewin-Koh Nicholas   Merchant Mark   Salphati Laurent  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 133-143

Springer Publishing Company

Access to resources Recommend Favorite

UPLCPDA determination of paeoniflorin in rat plasma following the oral administration of Radix Paeoniae Alba and its effects on rats with collageninduced arthritis

By                    

Experimental and Therapeutic Medicine, Vol. 7, Iss. 1, 2014-01 ,pp. : 209-217

Spandidos Publications

Access to resources Recommend Favorite

Comparison between the pharmacokinetics of meranzin hydrate in a rat model of chronic depression and in controls following the oral administration of Chaihu-Shugan-San

By                  

Experimental and Therapeutic Medicine, Vol. 6, Iss. 4, 2013-01 ,pp. : 913-918

Spandidos Publications

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins v 3 and v 5 in patients with advanced solid tumours

By Eskens F.A.L.M.   Dumez H.   Hoekstra R.   Perschl A.   Brindley C.   Bottcher S.   Wynendaele W.   Drevs J.   Verweij J.   van Oosterom A.T.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 917-926

Elsevier

Access to resources Recommend Favorite

CInQ-03, a novel allosteric MEK inhibitor, suppresses cancer growth in vitro and in vivo

By Kim Dong Joon  

Carcinogenesis, Vol. 34, Iss. 5, 2013-05 ,pp. : 1134-1143

Oxford University Press

Access to resources Recommend Favorite